Clinical Trials · NCT01345734
Non-Interventional Study on Safety of Liraglutide in Subjects With Type 2 Diabetes
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 1,056
- Start date
- Sep 2011
- Locations
- 1 site, Philippines
- Primary endpoint
- Incidence of serious adverse drug reactions (SADRs)